This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy.  Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia.

Faculty

Hanny Al-Samkari, MD
Classical Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Kevin H.M. Kuo, MD, MSc, FRCPC
Clinician-Investigator and Clinical Lead
Red Blood Cell Disorders Program
Division of Medical Oncology and Hematology
Department of Medicine
University Health Network
Associate Professor
Division of Hematology
Department of Medicine
Assistant Professor (status)
Institute of Health Policy
Management and Evaluation
Dalla Lana School of Public Health
University of Toronto
Toronto, Canada